Fluoride

Fluoride

SCHEMBL5833022

CCCCC[S].F.F.F.F.F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.50
THRB P10828 1/20 0.50
LMNA P02545 3/20 0.43
SLC22A1 O15245 3/20 0.39
SLC22A2 O15244 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
DNM1 Q05193 5/20 0.37
ALDH1A1 P00352 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL8959496 1.00
Fluoride SCHEMBL9710990 0.96 TSHR (0.57) TSHRTHRBLMNASLC22A1DNM1
Fluoride SCHEMBL9710983 0.96 TSHR (0.57) TSHRTHRBLMNASLC22A1DNM1
SCHEMBL37854 0.96
SCHEMBL77259 0.92 TSHR (0.61) TSHRTHRBLMNASLC22A1DNM1
SCHEMBL1611286 0.92 TSHR (0.61) TSHRTHRBLMNASLC22A1DNM1
SCHEMBL6406967 0.92 TSHR (0.50) TSHRTHRBLMNASLC22A1SLC22A2
SCHEMBL133112 0.92 TSHR (0.61) TSHRTHRBLMNASLC22A1DNM1
SCHEMBL371663 0.92 TSHR (0.61) TSHRTHRBLMNASLC22A1DNM1
SCHEMBL129166 0.92 TSHR (0.61) TSHRTHRBLMNASLC22A1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116940551-A Method for producing aryl compound containing pentafluorothio group AGC株式会社 2023-10-24 CN disclosed
EP-2468720-A1 Process for producing arylsulfur pentafluorides UBE Industries, Ltd. (JP) 2012-06-27 EP disclosed
US-7015176-B2 Process for the synthesis of aryl sulfurpentafluorides AIR PRODUCTS AND CHEMICALS, INC. (US) 2006-03-21 US disclosed
US-7015176-B2 Process for the synthesis of aryl sulfurpentafluorides AIR PRODUCTS AND CHEMICALS, INC. (US) 2006-03-21 US disclosed
US-6958415-B2 Synthesis of pentafluorosulfuranyl arylenes AIR PRODUCTS AND CHEMICALS, INC. (US) 2005-10-25 US disclosed
EP-1533297-A1 Synthesis of pentafluorosulfuranyl arylenes AIR PRODUCTS AND CHEMICALS, INC. (US) 2005-05-25 EP disclosed
US-20050107632-A1 Synthesis of pentafluorosulfuranyl arylenes AIR PRODUCTS AND CHEMICALS, INC. 2005-05-19 US disclosed
US-20040249209-A1 Process for the synthesis of aryl sulfurpentafluorides AIR PRODUCTS AND CHEMICALS, INC. 2004-12-09 US disclosed
US-20040249209-A1 Process for the synthesis of aryl sulfurpentafluorides AIR PRODUCTS AND CHEMICALS, INC. 2004-12-09 US disclosed
EP-1484318-A1 Process for the synthesis of aryl sulfurpentafluorides AIR PRODUCTS AND CHEMICALS, INC. (US) 2004-12-08 EP disclosed
EP-1484318-A1 Process for the synthesis of aryl sulfurpentafluorides AIR PRODUCTS AND CHEMICALS, INC. (US) 2004-12-08 EP disclosed
CN-1084733-C The Preparation of fluorinated organic compounds F2 CHEMICAL CO LTD (GB) 2002-05-15 CN disclosed
CN-1165512-A Process for preparing fluorinated organic compounds BRITISH NUCLEAR FUELS PLC (GB) 1997-11-19 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040249209-A1 Process for the synthesis of aryl sulfurpentafluorides PFAS, FLI1, AFF4 TSHR 1112/4885THRB 3703/4885LMNA 4480/4885
US-20050107632-A1 Synthesis of pentafluorosulfuranyl arylenes TST, DHRS9, HDHD5 TSHR 67/4885THRB 900/4885LMNA 4428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.